Breaking news

Volkswagen’s Cost-Cutting Plan Faces Scrutiny As Traditional Methods Clash with Bold Promises

Volkswagen’s recent cost-cutting agreement, hailed as crucial for its survival amidst increasing competition and declining demand, leans heavily on the company’s longstanding tradition of collaboration between management and workers. However, this approach has sparked concerns among investors about the company’s ability to meet its ambitious targets, including reducing capacity and cutting 35,000 jobs.

The deal, which was reached just before Christmas, aims to tackle the company’s challenges, with workers and unions now engaging in discussions at factories across Germany to clarify the details. According to company sources, each plant will be given its cost-reduction target, with mixed teams of managers and labor representatives working together to devise strategies that enhance productivity. These targets will be reviewed quarterly, and if any interim milestones are missed, new negotiations may be necessary.

This method aligns with Volkswagen’s history of compromise and cooperation, but it also raises questions about its effectiveness in driving the required changes. The model avoids a top-down restructuring approach that might have been more decisive but could have led to unrest or strikes.

Investors have been left underwhelmed by the deal, with Volkswagen shares trading below the levels seen in October, before a sharp decline in quarterly profits. Analysts like Patrick Hummel from UBS believe the market needs to see concrete plans for long-term profitability, with a focus on how the cost-cutting measures will impact the company’s bottom line in the next two years.

Capacity Reductions And Plant Closures Remain Uncertain

As the deal progresses, questions persist about how Volkswagen will reduce its workforce and production capacity. Unions have been informed that the company is considering closing three to four plants, though Volkswagen has declined to confirm specific closures. The final agreement does include the closure of two factories: one in Dresden by 2025, and another in Osnabrueck by 2027. However, both sites may be repurposed for alternative uses, with potential new investors involved.

The company’s Zwickau plant, which produces electric vehicles, will lose one production line but will receive investment in a new recycling facility, which is set to begin operations in 2027. These new investments, however, are contingent on meeting cost-cutting goals, as Volkswagen’s finance chief Arno Antlitz made clear in recent comments to investors.

The company has also identified capacity reductions at its Wolfsburg headquarters, where two production lines will be cut. While Volkswagen has stated that the deal will result in savings of €15 billion over the “medium term,” investors remain uncertain about how this approach compares to the more direct route of plant closures.

Job Cuts Remain A Major Challenge

Another pressing concern is how Volkswagen will achieve its target of shedding 35,000 jobs. While the company previously promised to cut 30,000 jobs in 2016, its workforce size has remained largely stable due to new hires in other areas. The current plan to meet the target relies on not replacing retiring employees and offering voluntary early or partial retirement options. A clause in the deal guarantees jobs until 2030, a concession won by unions after Volkswagen canceled a previous job guarantee agreement in September.

Despite the uncertainties surrounding the cost-cutting plan, some analysts believe that Volkswagen’s CEO, Oliver Blume, has done well in navigating the complexities of dealing with unions and local politicians, who have significant influence over the company’s decisions. Moritz Kronenberger, portfolio manager at Union Investment, notes that although the deal may appear underwhelming, it represents deeper cuts than many had anticipated.

Blume’s leadership is under scrutiny. As Kronenberger points out, “Blume remains the right CEO, but the company’s cost structure must look very different in two years. Volkswagen needs to prove it’s ready for the future and can continue to produce attractive products.” For now, Blume’s ambitious promises have left him both vulnerable and accountable as Volkswagen seeks to secure its future in a rapidly changing industry.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

eCredo
Uol
Aretilaw firm
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter